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ABSTRACT
Objectives To assess the effects of different official 
information on public interpretation of a personal 
COVID-19 PCR test result.
Design A 5×2 factorial, randomised, between- subjects 
experiment, comparing four wordings of information 
about the test result and a control arm of no additional 
information; for both positive and negative test results.
Setting Online experiment using recruitment platform 
Respondi.
Participants UK participants (n=1744, after a pilot of 
n=1657) quota- sampled to be proportional to the UK 
national population on age and sex.
Interventions Participants were given a hypothetical 
COVID-19 PCR test result for ‘John’ who was presented 
as having a 50% chance of having COVID-19 based 
on symptoms alone. Participants were randomised to 
receive either a positive or negative result for ‘John’, then 
randomised again to receive either no more information, 
or text information on the interpretation of COVID-19 test 
results copied in September 2020 from the public websites 
of the UK’s National Health Service, the USA’s Centers 
for Disease Control, New Zealand’s Ministry of Health 
or a modified version of the UK’s wording. Information 
identifying the source of the wording was removed.
Main outcome measures Participants were asked ‘What 
is your best guess as to the percent chance that John 
actually had COVID-19 at the time of his test, given his 
result?’; questions about their feelings of trustworthiness 
in the result, their perceptions of the quality of the 
underlying evidence and what action they felt ‘John’ 
should take in the light of his result.
Results Of those presented with a positive COVID-19 
test result for ‘John’, the mean estimate of the probability 
that he had the virus was 73% (71.5%–74.5%); for those 
presented with a negative result, 38% (36.7%–40.0%). 
There was no main effect of information (wording) on 
these means. However, those participants given the official 
information from the UK website, which did not mention 
the possibility of false negatives or false positives, were 
more likely to give a categorical (100% or 0%) answer (UK: 
68/343, 19.8% (15.9%–24.4%); control group: 42/356, 
11.8% (8.8%–15.6%)); the reverse was true for those 
viewing the New Zealand (NZ) wording, which highlighted 
the uncertainties most explicitly (20/345: 5.8% (3.7%–
8.8%)). Aggregated across test result (positive/negative), 
there was a main effect of wording (p<0.001) on beliefs 
about how ‘John’ should behave, with those seeing the NZ 
wording marginally more likely to agree that ‘John’ should 
continue to self- isolate than those viewing the control or 
the UK wording. The proportion of participants who felt 
that a symptomatic individual who tests negative definitely 
should not self- isolate was highest among those viewing 
the UK wording (31/178, 17.4% (12.5%–23.7%)), and 
lowest among those viewing the NZ wording (6/159, 3.8% 
(1.6%–8.2%)). Although the NZ wording was rated harder 
to understand, participants reacted to the uncertainties 
Strengths and limitations of this study
 ► This study provides the first empirical evidence, to 
our knowledge, of how the public interpret the inher-
ent uncertainty around COVID-19 test results, and 
information given alongside such results.
 ► The study was carried out on a large quota- sampled 
pool of UK participants, and tested wording taken 
from official websites in three countries about the 
interpretation of COVD-19 test results. However, the 
wording on these websites is likely different from 
the information provided to individuals immediately 
after their tests in the respective countries.
 ► A limitation of the study is that the prior probability 
of infection (based on symptoms/background preva-
lence) of the individual in our scenario was very high 
(50%), which would not commonly be the case. This 
was chosen as we felt it would not bias participants 
towards believing that the individual did or did not 
have COVID-19 before his test result was revealed, 
making the results easier to interpret.
 ► All behavioural responses from participants were 
purely hypothetical and framed as what the recip-
ient of such a test result should do, so should be 
interpreted with caution.
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given in the text in the expected direction: there was a small main effect 
of wording on trust in the result (p=0.048), with people perceiving the test 
result as marginally less trustworthy after having read the NZ wording 
compared with the UK wording. Positive results were generally viewed as 
more trustworthy and as having higher quality of evidence than negative 
results (both p<0.001).
Conclusions The public’s default assessment of the face value of 
both the positive and negative test results (control group) indicate an 
awareness that test results are not perfectly accurate. Compared with 
other messaging tested, participants shown the UK’s 2020 wording about 
the interpretation of the test results appeared to interpret the results as 
more definitive than is warranted. Wording that acknowledges uncertainty 
can help people to have a more nuanced and realistic understanding of 
what a COVID-19 test result means, which supports decision making and 
behavioural response.
Preregistration and data repository Preregistration of pilot at  osf. io/ 
8n62f, preregistration of main experiment at  osf. io/ 7rcj4, data and code 
available online ( osf. io/ pvhba).
INTRODUCTION
PCR tests for COVID-19 are widely used in many countries 
to help individuals take appropriate action such as self- 
quarantining and initiating contact- tracing. At a popula-
tion level, they give policymakers vital information about 
the prevalence of the virus. However, the sensitivity and 
specificity of the tests (especially in real- world scenarios) 
are not 100%. Therefore, people taking action on the 
basis of test results need to be aware of the potential that 
for an individual, a single negative test may not be an ‘all 
clear’. Similarly, it is important to be transparent that a 
positive test does not equate to a 100% chance that one 
carries the virus. Watson et al1 created a tool to help with 
the interpretation of such tests. Using the approximate 
sensitivity and specificity values posited in Watson et al1 
on the basis of systematic reviews suggests that a positive 
test result with a prior suspicion of COVID-19 of 50% 
should be interpreted as around a 93% chance that the 
patient had COVID-19 at the time they were tested, and 
a negative test as around a 24% chance.1 A recent assess-
ment of the UK Office for National Statistics estimated a 
false positive rate of under 0.005%,2 suggesting that even 
more confidence about the interpretation of a positive 
test result may be warranted.
However, the wording provided to support public 
interpretations of the test results varies from country 
to country. As of 2020, in the UK, the National Health 
Service (NHS) website on test interpretation expressed 
no uncertainty (e.g., ‘A positive result means you had 
coronavirus when the test was done’ and ‘A negative result 
means the test did not find coronavirus’).3 On an equiv-
alent US website from the Centers for Disease Control, 
the phrasing communicated slightly more uncertainty 
(e.g., ‘If you test positive, know what protective steps to 
take to prevent others from getting sick’ and ‘If you test 
negative, you probably were not infected at the time your 
sample was collected. The test result only means that 
you did not have COVID-19 at the time of testing’).4 5 By 
contrast, in New Zealand (NZ), a much longer wording 
was provided by the Ministry of Health which included far 
more information about the uncertainties inherent in the 
test (e.g., ‘A recent laboratory study found that different 
COVID-19 testing kits correctly detected COVID-19 in 
samples more than 95% (and frequently 100%) of the 
time. When tests were done on samples without the virus, 
the tests correctly gave a negative result 96% of the time. 
But it is important to remember that tests don’t work as 
well in the real world.’ and ‘The viral test for COVID-19 
is much better at correctly identifying people who don’t 
have COVID-19 (this is known as a higher ‘specificity’). 
We expect very few (if any) false positive test results (a 
false positive being a positive test result for someone who 
does not have the disease)’.)6
Concern has been expressed that information provided 
to patients without uncertainty may cause unwarranted 
confidence in the results, particularly negative results.7 
For example, if a negative test result is communicated 
as ‘you do not have coronavirus’, patients may take this 
statement at face value. However, if made aware that the 
results are sometimes wrong, they might become less 
certain about the meaning of the result. It is common 
to ask participants to provide subjective probabilities as 
a way of quantifying their uncertainty (both aleatory and 
epistemic).8–11 It is important to note that such estimates 
should not be interpreted as calculations of real- world 
probabilities, or as readouts of probabilities assumed 
to exist ‘in the head’; instead, they are likely to reflect 
an interplay of a range of psychological processes.12–14 
Nevertheless, there are good reasons to believe that such 
estimates do at least partially reflect participants’ subjec-
tive beliefs15 and do have predictive validity when used to 
assess likelihoods of future events.9–11 16 In particular, the 
endpoints of the scale (100% and 0%) can be interpreted 
as extremely high certainty (that ‘John’ does or does not 
have the virus, respectively). The mid- point in English 
language surveys (50%) needs particular care in interpre-
tation due to well- recognised lay usage of the term ‘fifty- 
fifty’ as a communication of ‘I don’t know’,17–19 but in any 
case, seems to communicate high levels of uncertainty. 
Our analyses therefore pay particular attention to these 
responses.
In addition to potentially affecting people’s subjec-
tive beliefs about their COVID-19 status, decisions about 
whether and how to communicate uncertainty may also 
affect perceptions about the quality of evidence behind 
the information, and their level of trust in it.20–27 For 
example, Johnson and Slovic28 show that communication 
of uncertainty can have effects on perceived honesty and 
competence of the communicator. Broomell and Kane29 
report that perceptions of precision of the information, 
as a function of the communication of uncertainty, can 
influence people’s perceived value of it. People’s assess-
ment of the information they are provided with in terms 
of credibility and confidence furthermore influences 
decision making and behaviour.30 31 In the public health 
domain, Han31 argues that ‘people not only need but 
deserve information about uncertainty’ (p15S), high-
lighting the importance of informed decision making 
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and the ethical principle of respect for patient autonomy. 
Investigating how the communication of uncertainty 
affects people’s judgement of the information at hand and 
their behavioural intentions is thus critically important. 
In an experimental study in the context of COVID-19 
public health communication, Wegwarth et al showed that 
participants preferred communication which explicitly 
stated uncertainty (in verbal and numeric format), both 
when asked how government and health experts should 
communicate, as well as when asked if the communication 
would motivate their compliance.32 Finally, as alluded to 
above, there are ethical considerations to be weighed up 
around whether the goal should be to inform individuals 
so that they are well- positioned to take self- determined 
actions without coercion (see Blastland et al33 for argu-
ments in favour of this view), as opposed to persuading 
them to adopt a particular course of action. Note that 
more belief, trust and so on in a test result is not neces-
sarily always good, even from the perspective of a public 
health official who wishes to persuade: if there is substan-
tial uncertainty around a test’s negative predictive value 
for individuals with symptoms, public health officials may 
well prefer symptomatic individuals with negative tests to 
exercise caution and self- isolate anyway.
This study set out to test the effects of different 
approaches to communicating COVID-19 PCR test results 
on how likely participants thought it was that the test 
recipient actually had COVID-19, on their perception 
of the quality of the evidence underlying the test result, 
the trustworthiness of the test result, and on participants’ 
views about whether positive/negative test result recipi-
ents should self- isolate. After a pilot study (see online 
supplemental information) we created an experimental 
version of the information (‘experimental information’ 
condition), based on the UK’s NHS website wording but 
containing elements to make the uncertainties explicit. 
These elements were based loosely on the detailed uncer-
tainty information provided on the New Zealand Ministry 
of Health website, but with less detail.
Preregistered hypotheses
We preregistered four hypotheses ( osf. io/ 7rcj4) based 
on the findings of the pilot. Our specific research ques-
tions and corresponding hypotheses are summarised in 
table 1. In general, the pilot findings seemed to suggest 
a level of scepticism about positive test results after 
reading the UK or US information that was not present 
in other messaging conditions. We suspected this could 
be the case because the UK and US information did not 
explicitly note that positive test results were more reliable 
than negative test results, or indeed say much about the 
reliability of the tests at all (table 2), despite this being a 
hot topic in the news at the time. We reasoned that the 
absence of such information may have caused readers to 
be ‘on their guard’.
METHODS
Participants aged 18+ were recruited for the main study online 
through the ISO- accredited company Respondi and directed 
Table 1 Research questions and preregistered hypotheses
Research question Pilot result Formal hypothesis
Q1: What influence do message 
wording and test result have on 
how likely participants thought 
it was that the test recipient 
actually had COVID-19?
For participants in the ‘positive’ test result 
condition, estimates of the probability that 
‘John’ actually had COVID-19 were lower 
for those shown the UK or US information 
than for those shown the New Zealand 
information or no information at all
H1: Interaction such that for participants in the ‘positive’ test 
result condition, estimates of the probability that ‘John’ 
actually had COVID-19 will be lower for those shown the 
UK or US information than for those shown the New Zealand 
information, no information at all or experimental information 
based on the UK wording
Q2: What influence do message 
wording and test result have on 
participants’ views of the quality 
of the evidence behind ‘John’s’ 
test result?
Participants viewing no information 
perceived the quality of evidence 
behind the test to be higher if they had 
been shown positive (vs negative) test 
results; this difference was not found for 
participants viewing UK or US information
H2: Interaction such that participants viewing no information or 
experimental information who are shown positive test results will 
perceive the quality of evidence to be greater than individuals 
shown the same information and negative test results, whereas 
this difference will not be found for individuals shown US and UK 
information
Q3: What influence do message 
wording and test result have 
on participants’ views of the 
trustworthiness of ‘John’s’ test 
result?
Participants viewing no information 
and NZ information perceived the test 
result to be more trustworthy if they had 
been shown positive (vs negative) test 
results; this difference was not found for 
participants viewing UK information*
H3: Interaction such that participants viewing no information or 
experimental information who are shown positive test results will 
perceive the test result to be more trustworthy than individuals 
shown the same information and negative test results, whereas 
this difference will not be found for individuals shown US and UK 
information
Q4: What influence do message 
wording and test result have 
on participants’ views about 
whether ‘John’ should self- 
isolate?
Pilot did not investigate participants’ 
estimation of whether someone with a 
positive/negative result should self- isolate, 
but a hypothesis was generated on the 
basis of the results above
H4: Interaction such that participants viewing no information or 
experimental information who are shown positive test results 
will indicate greater agreement with the statement that ‘John’ 
should self- isolate than individuals shown the same information 
and negative test results, whereas this difference will not be 
found for individuals shown US and UK information
Dependent variables are in bold.
*The difference was found for US information, but with less confidence than for the New Zealand (NZ) and control conditions; due to the 
inconsistency with the other results, we assessed this as likely to be a false positive for the purposes of defining our formal hypotheses.
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to a questionnaire in Qualtrics. Participants completed the 
questionnaire between 29 October and 2 November 2020. 
All participants gave informed consent before participation 
and were randomised afterwards using the ‘randomise’ 
function in Qualtrics. Participants were presented with the 
scenario ‘John has been feeling ill. Based on his symptoms 
alone, a knowledgeable doctor believes that John has a 50–50 
chance of having COVID-19. John takes the COVID-19 
(swab) test to see whether he currently has the virus, and it is 
…’ with the final word of the sentence being positive or nega-
tive, depending on whether they had been randomised into 
the positive or negative ‘test result’ condition. We also placed 
the final word of the sentence in bold font, to increase the 
likelihood that participants would read and remember the 
result. Participants were then further randomised to one 
of five ‘information’ conditions. Those in a control condi-
tion received no further information; others were given the 
explanatory text around interpreting COVID-19 test results 
used on official websites produced by one of the following: 
the UK’s NHS, the USA’s Centers for Disease Control, New 
Zealand’s Ministry of Health or the experimental informa-
tion described previously. All information that could be used 
by participants to identify the original source/country of 
the text was removed. The full texts given to participants are 
shown in the online supplemental information.
Participants were then asked a series of questions, 
including: ‘What is your best guess as to the percent 
chance that John actually had COVID-19 at the time of his 
test, given his result?’, which participants answered on a 
slider scale; questions about their impression of the accu-
racy, reliability, certainty and trustworthiness of the result, 
which were combined into an index measure of ‘perceived 
trustworthiness’; the quality of the evidence underlying 
the test result; their confidence in their estimate of the 
chance that ‘John’ had COVID-19; and—for participants 
not in the control condition—how clear and easy to 
understand they felt the information to be, answered on 
7- point Likert scales. The first three measures were part of 
our set of key dependent outcome variables as described 
earlier. Our index measure of perceived trustworthiness 
was based on the findings of the pilot, in which answers to 
the questions on certainty, accuracy, reliability and trust-
worthiness were highly correlated (all r>0.7, Cronbach’s 
alpha=0.95), and were therefore averaged into a single 
index of perceived trustworthiness.
All participants were also asked ‘Given John’s test 
result, how much do you agree or disagree with the state-
ment that ‘John should now isolate himself from other 
people’?’, which was our fourth key dependent variable. 
They answered on a slider scale between ‘completely 
disagree’ to ‘completely agree’, which was converted to 
0–100 for analysis. Afterward, participants were asked 
‘What are your reasons for your answer above?’ and given 
a free text response box. Free response answers were 
coded by one of the authors into categories capturing the 
most prominent themes that emerged from their assess-
ment of the responses via inductive coding.34 They were 
also asked a number of demographic questions and ques-
tions about their experience with, and perception of the 
risk of, COVID-19.
Timers were also set to measure the amount of time 
participants spent reading the information and answering 
the sets of questions. Full details of all questions and their 
answer options are shown in the online supplemental 
information.
In the pilot experiment, participants had been asked 
to type in their best guess as to the per cent chance that 
‘John’ actually had COVID-19 at the time of his test. For 
the main experiment this was changed to a slider and 
labels added to confirm ‘0%: John definitely did not have 
COVID-19’ and ‘100%: John definitely did have COVID-
19’. This was done because in the pilot, close to half of 
participants typed in ‘50%’ as their answer, which is well 
known as a response that some individuals use to indicate 
that they do not know the answer; this tendency can be 
mitigated by providing a slider.17–19
Power calculation
Based on the effect sizes achieved in the pilot, we calcu-
lated that 1643 participants would be required to achieve 
90% power to detect an effect size of ηp
2=0.009 (f=0.097), 
and adjusted our total required sample upwards on the 
Table 2 Key characteristics of message wording from each country; full wording in online supplemental information
Short title Original source*
Word 
count Communicates possibility of false positive? Communicates possibility of false negative?
US wording US Centers for Disease 
Control and Prevention
225 No Indirectly (‘you probably were not infected at the 
time your sample was collected’, with further caveat 
implying that you could be infected now even if you 
were not infected when the sample was taken)
New Zealand 
wording
New Zealand Ministry 
of Health
548 Indirectly, as a remote possibility (‘We expect 
very few (if any) false positive test results (a false 
positive being a positive test result for someone 
who does not have the disease’)
Yes (paragraph about reasons why false negatives are 
possible)





UK National Health 
Service (modified by 
researchers)
613 Indirectly, as a remote possibility (‘A positive 
result means you almost certainly had 
coronavirus when the test was done’)
Yes (paragraph about reasons why false negatives are 
possible)
*Wording retrieved from original sources in September 2020.
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assumption that the same proportion of participants would 
fail the attention check as did in the pilot. Consequently, we 
intended to sample 2041 participants; due to slight oversam-
pling, our final sample contained 2049 participants.
Preregistered analyses
5 (message wording)×2 (test result) analyses of variance 
(ANOVAs) were preregistered for each primary dependent 
variable: participants’ estimates of ‘John’s’ chance of having 
COVID-19, the perceived quality of evidence behind ‘John’s’ 
test result, the trustworthiness of ‘John’s’ test result and level 
of agreement with the statement ‘John should now isolate 
himself from other people’. One of the assumptions of an 
ANOVA is normality of residuals. Although the technique is 
reasonably robust to violations of this assumption,35 36 viola-
tions can lead to increased probability of type I errors and loss 
of power,36 so alternatives are sometimes suggested for severe 
normality violations. One reason to expect such violations is 
the aforementioned tendency of many participants to answer 
50% to indicate ‘I don’t know’ in studies where participants 
are asked to estimate probabilities of events,17 such as for our 
first key dependent outcome measure which asked partici-
pants to estimate the chance (in per cent) that ‘John’ had 
COVID-19 at the time of the test. Although we implemented 
a slider scale to mitigate the problem, we still anticipated 
that a substantial proportion of participants would provide 
midpoint answers. We therefore noted in our preregistration 
that non- parametric tests would be substituted if ANOVA 
assumptions were sufficiently violated. We also aimed to look 
for differences among the different wording groups in the 
frequency of responses of ~50%, though this was not stated 
in the preregistration.
Because applying a simple rank transform prior to 
ANOVA can cause unreliable estimation of interactions, an 
approach known as aligned ranks transformation ANOVA37 
is recommended38 for factorial designs. These models always 
included the wording * test result interaction term. For regular 
parametric ANOVAs, we ran the model with the interaction 
term (using type 3 sums- of- squares), but when there was no 
interaction, we excluded the interaction term and reported a 
main- effects- only model (type 2 sums- of- squares).
Patient and public involvement
Patients and the public were not involved in the design 
or coproduction of this study. The results will be dissemi-
nated to study participants who requested it.
RESULTS
Characteristics of the participants in the main study are 
shown in table 3. The questionnaire took a median of 
14 minutes for participants to complete, and they were 
paid £0.75 for their participation. Analysis was conducted 
in R (V.3.6). Two hundred and ninety- seven participants 
did not pass the attention check and were excluded from 
all analyses. Final analytical sample sizes are reported in 
table 4.
Residuals of the dependent variables of ‘chance of 
COVID-19’ (H1) and level of agreement with the state-
ment that ‘John’ should self- isolate (H4) had fairly severe 
levels of non- normality, despite our use of slider scales. 
Aligned ranks transformation ANOVAs were therefore 
conducted for these two analyses.





Gender Male 834 (48)
Female 910 (52)


















No formal education above 
age 16
225 (13)
Professional or technical 
qualifications above age 16
325 (19)
School education up to age 18 460 (26)
Degree (Bachelors) or 
equivalent
528 (30)




Participants quota- sampled from the UK, 2020.
*Numeracy measured by a combination of the adaptive Berlin 
numeracy test,48 three questions from Schwartz et al,49 and one 
from Lipkus et al.50







New Zealand 186 159
Experimental 200 158
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Q1: What influence did message wording and test result 
have on how likely participants thought it was that the test 
recipient actually had COVID-19?
An aligned ranks transformation ANOVA found a large 
main effect of test result (F(1,1734)=976.2, table 5), with 
those who were told that ‘John’s’ test result was positive 
having a stronger belief that he had COVID-19 than those 
told his result was negative. However, there was no main 
effect of message wording and no interaction; this was 
also true after removing participants seemingly using 50% 
to indicate ‘I don’t know’ (see online supplemental anal-
ysis 1). The results therefore did not confirm hypothesis 
H1. Exploratory one- way ANOVAs likewise found no 
main effect of message wording in either those who were 
presented with a positive test result or those presented 
with a negative result (figure 1).
Q2: What influence did message wording and test result have 
on participants’ views of the quality of the evidence behind 
‘John’s’ test result?
We found a small main effect of test result on perceived 
quality of evidence (F(1,1738)=37.09, table 5): partici-
pants felt quality of evidence was higher for positive test 
results than negative test results (see also figure 2). As 
Table 5 Main effects of test result
Research 
question
Mean (95% CI) Median (95% CI)*
P value ηp
2Positive test Negative test Positive test Negative test
Q1 72.96 (71.46 to 74.46) 38.38 (36.71 to 40.05) 75 (71 to 76) 50 (41.5 to 50) <0.001 0.360
Q2 5.21 (5.12 to 5.30) 4.83 (4.74 to 4.92) 5.38 (5.26 to 5.38) 4.96 (4.78 to 5.02) <0.001 0.021
Q3 5.17 (5.07 to 5.26) 4.75 (4.66 to 4.85) 5.35 (5.18 to 5.59) 4.92 (4.83 to 5.00) <0.001 0.023




72.30 (70.66 to 73.94) 63.99 (62.21 to 65.77) 76.5 (74 to 79) 67 (62 to 68) <0.001 0.027
*CIs of the median computed using the adjusted percentile bootstrap method.51
Figure 1 Distributions of participants’ estimates of the chances of the test recipient ‘John’ actually having COVID-19, given 
either a negative (left hand side) or positive (right hand side) test result, and with either no accompanying explanatory text 
(control wording), an experimental text based on the UK wording but with added clarification about the test uncertainties 
(experimental wording), or official text from one of three different countries, that is, New Zealand (NZ wording), UK (UK wording), 
USA (US wording). The large hump around 50% is often interpreted as a response from participants who ‘don’t know17’. Red 
markers indicate group mean and 95% CI.
7Recchia G, et al. BMJ Open 2021;11:e047731. doi:10.1136/bmjopen-2020-047731
Open access
we did not find a main effect of wording or a significant 
interaction, hypothesis H2 was not confirmed.
Q3: What influence did message wording and test result have 
on participants’ views of the trustworthiness of ‘John’s’ test 
result?
We found a small main effect of test result on perceived 
trustworthiness (F(1,1738)=40.42, table 5), with partic-
ipants perceiving the positive test results as more trust-
worthy than the negative test results (see also figure 3). 
We additionally found a small main effect of wording 
(F(4,1738)=2.41, table 6), with Tukey’s post- hocs 
suggesting that participants rated the test result as slightly 
less trustworthy if they read the NZ wording (mean=4.81, 
95% CI 4.67 to 4.94) than if they read the UK wording 
(mean=5.10, 95% CI 4.96 to 5.25), padj=0.020. The effect 
of wording was only significant when the (non- significant) 
interaction term is removed from the model, and was not 
found in the pilot. As we did not find a significant interac-
tion, hypothesis H3 was not confirmed.
Q4: What influence did message wording and test result have 
on participants’ views about whether ‘John’ should self-
isolate?
Aligned ranks transformation ANOVA revealed a large 
main effect of test result (F(1,1734)=699.3, table 5): 
Most participants who were given a positive result for 
‘John’ very much agreed with the statement that ‘John’ 
should isolate (median=97, 95% CI 93 to 98), whereas 
participants who saw the negative condition exhibited 
more divergent opinions (median=58.5, 95% CI 54 to 
61.5). Many of those who were told he had a negative 
result still agreed he should isolate: 41% (N=354) of 
those who were told he had a negative result still placed 
the slider at least two- thirds of the way towards the right-
most endpoint of the scale. This analysis also revealed a 
small main effect of wording (F(4,1734)=8.27, table 6). 
CIs and post- hoc Mann- Whitney tests suggested more 
agreement with the statement among participants 
viewing the NZ wording than among those viewing 
the control or the UK wording (CIs in table 7). There 
was also a small interaction (F(4,1734)=8.51, p<0.001, 
ηp
2=0.019), described later; means and CIs for each 
condition are given in table 7, and full distributions in 
figure 4.
The results partially confirm hypothesis H4, that there 
would be an interaction between wording and test result. 
Those shown a positive test result were more likely to 
agree that the recipient should self- isolate, but the differ-
ences among the wording groups were not as hypothe-
sised. Instead, participants who viewed the NZ wording 
trended towards being more cautious in the case of a 
negative result (table 7). That said, 95% CIs between all 
pairs of wordings for a given test result overlapped at least 
slightly, and as mentioned, overall agreement that ‘John’ 
should self- isolate (aggregating across test results) was 
highest for those viewing the NZ wording.
Figure 2 Distributions of participants’ perception of the quality of the evidence underlying ‘John’s’ PCR test result (rated on 
a 1–7 Likert scale with 1 indicating low quality of evidence and 7 indicating high quality of evidence) given either a negative 
(left hand side) or positive (right hand side) test result, and with either no accompanying explanatory text (control wording), an 
experimental text based on the UK wording but with added clarification about the test uncertainties (experimental wording), or 
official text from one of three different countries, that is, New Zealand (NZ wording), UK (UK wording), USA (US wording). Red 
markers indicate group mean and 95% CI.
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Exploratory analyses
50% responses: beliefs about ‘John’s’ COVID-19 status
Overall for our measure of likelihood that ‘John’ had 
COVID-19 at the time of testing, 25.4% of participants 
gave an answer between 48% and 52% (a range we 
defined around the 50% midpoint given that people may 
not achieve exact accuracy with the slider), a phenom-
enon that is commonly observed and is attributed to 
‘50–50’ being akin to ‘I don’t know’.17 18 There was no 
difference in the prevalence of this answer among the 
different wording groups with the possible exception 
of participants who saw the NZ wording, of whom only 
19.1% gave answers between 48% and 52%: An explor-
atory χ2 test suggested a possible difference (p<0.05) 
when participants in the NZ condition were included, 
but not when they were excluded. In addition to partici-
pants answering 50%, participants answering 0% or 100% 
were also of particular interest, as these answers arguably 
suggest more certainty than is warranted about the impli-
cations of a positive or negative test result.
Figure 3 Distributions of participants’ perception of the trustworthiness of ‘John’s’ PCR test result (rated on a 1–7 Likert scale 
with 1 indicating low trustworthiness and 7 indicating high trustworthiness) given either a negative (left hand side) or positive 
(right hand side) test result, and with either no accompanying explanatory text (control wording), an experimental text based on 
the UK wording but with added clarification about the test uncertainties (experimental wording), or official text from one of three 
different countries, that is, New Zealand (NZ wording), UK (UK wording), USA (US wording). Red markers indicate group mean 
and 95% CI.





2Control USA New Zealand UK Experimental
Q3 4.96 (4.81 to 
5.12)
4.96 (4.82 to 5.11) 4.81 (4.67 to 
4.94)
5.10 (4.96 to 
5.25)
4.96 (4.81 to 
5.11)
0.048 0.006
Q4 64.65 (60.95 to 
68.35)
70.27 (66.93 to 
73.61)
72.54 (69.41 to 
75.68)
65.40 (61.71 to 
69.09)
68.70 (65.36 to 
72.04)
<0.001 0.019
Confidence in Q1 
estimate
(exploratory)
69.92 (67.31 to 
72.52)
67.83 (64.99 to 
70.67)
63.96 (61.18 to 
66.73)
70.31 (67.51 to 
73.12)






n/a 5.61 (5.48 to 5.75) 5.11 (4.96 to 
5.27)
5.43 (5.28 to 
5.59)







n/a 4.34 (4.16 to 4.53) 5.00 (4.84 to 
5.17)
4.69 (4.49 to 
4.89)
4.73 (4.54 to 
4.91)
<0.001 0.018
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‘Categorical’ 100% or 0% responses: beliefs about ‘John’s’ 
COVID-19 status
When asked how likely it was that ‘John’ actually had 
COVID-19 at the time of his test result, a χ2 test suggested 
there were differences among wording groups in terms of 
likelihood to provide categorical ‘100%’ or ‘0%’ answers 
in the positive and negative test scenarios (100%: χ2(4, 
N=872)=22.1, p<0.001; 0%: χ2(4, N=872)=14.4, p=0.006; 
both: χ2(4, N=1744)=32.0, p<0.001). Follow- up χ2 tests 
and inspection of CIs suggested these differences were 
largely due to the participants who saw the UK wording 
being more likely to give categorical responses, and 
participants who saw the NZ wording less likely to (see 
table 8 (second column) and figure 5A,B). Further detail 
is available in table 9. χ2 tests comparing the UK wording 
condition to each other group in turn suggested that 
those in the UK wording group were more likely to give a 
categorical response than every other group, and those in 
the NZ wording group were less likely to give a categorical 
Table 7 Mean agreement with the statement ‘John should 





Mean (95% CI) Mean (95% CI)
Control 88.07 (84.87 to 
91.27)
46.38 (41.63 to 51.14)
USA 87.62 (84.93 to 
90.31)
54.10 (49.21 to 58.98)
UK 83.27 (79.48 to 
87.06)
48.84 (43.72 to 53.95)
New Zealand 85.44 (82.81 to 
88.08)
57.46 (52.27 to 62.65)
Experimental 83.62 (80.55 to 
86.70)
49.81 (44.62 to 55.00)
Figure 4 Distributions of participants’ amount of disagreement (0) or agreement (100), with the statement that the test 
recipient ‘John’ should continue to self- isolate given either a negative (left hand side) or positive (right hand side) test result, and 
with either no accompanying explanatory text (control wording), an experimental text based on the UK wording but with added 
clarification about the test uncertainties (experimental wording), or official text from one of three different countries, that is, New 
Zealand (NZ wording), UK (UK wording), USA (US wording). Red markers indicate group mean and 95% CI.
Table 8 Participant responses to ‘What is your best guess 
as to the percent chance that John actually had COVID-19 







categorically (0% or 
100%) (percentage, 
95% CI52)
  Control 84/356
23.6% (19.5% to 
28.3%)
42/356
11.8% (8.8% to 15.6%)
  USA 98/342
28.7% (24.1% to 
33.7%)
42/342
12.3% (9.2% to 16.2%)
  New Zealand 66/345
19.1% (15.3% to 
23.6%)
20/345
5.8% (3.7% to 8.8%)
  UK 97/343
28.3% (23.8% to 
33.3%)
68/343
19.8% (15.9% to 24.4%)
  Experimental 98/358
27.4% (23% to 
32.2%)
41/358
11.5% (8.5% to 15.2%)
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response than any other group, all tests p<0.05. (Whether 
p values lose their meaning in exploratory analyses is a 
matter of some debate. We report them for reference but 
acknowledge that their interpretation is controversial; see 
Rubin39 for arguments on both sides.)
‘Categorical’ 100% or 0% responses: beliefs about whether ‘John’ 
should self-isolate
A χ2 test on the subset of participants who were told that 
‘John’ tested negative (after having been told he was expe-
riencing symptoms) suggested that participants were more 
likely to express maximal disagreement with the statement 
‘John should now isolate himself from other people’ if they 
were presented with the UK message (χ2(4, N=872)=23.9, 
p<0.001): 17.4% of those in the UK wording group expressed 
maximal disagreement, in contrast to 3.8% (NZ), 5.1% 
(USA), 8.9% (experimental) and 11.0% (control) (see 
table 10 for Ns and CIs). Further analyses were conducted 
on this subset of participants to see if these differences were 
likely to be meaningful: first, compared head- to- head with 
the control group, a χ2 test suggested that the NZ wording 
group was less likely to express maximal disagreement, χ2(1, 
N=359)=5.5, p=0.02. Second, head- to- head comparisons 
between the UK wording condition and each other group 
suggested that those in the UK wording group were more 
likely to express maximal disagreement than every other 
group except for the control, for which there was no clear 
difference. There was no clear evidence that participants 
who heard that ‘John’ had tested positive were more likely to 
express maximal agreement in one wording condition over 
another (χ2(4, N=872)=5.3, p=0.256).
How easy or difficult did participants find the information to 
understand?
As might be expected, ratings of understanding of the 
different wordings were associated with the length and 
the complexity of the text (e.g., description of the statis-
tical concepts of false negatives/false positives), with 
the NZ wording being rated the hardest to understand 
on average, and the US wording the easiest. A two- way 
ANOVA (test result+test wording) of ratings of ‘how 
easy’ people found the wording to understand and ‘how 
completely’ they felt they understood it (averaged into an 
index measure) suggested a small main effect of wording 
(F(3,1372)=7.89, table 6), with post- hoc Tukey tests 
implying that the NZ text was harder to understand than 
all three other wordings: UK (padj=0.012), USA (padj<0.001) 
and experimental wording (padj=0.009). An ANOVA of 
participants’ ratings of how much effort they had to put 
into understanding the wording also suggested a small 
main effect of wording (F(3,1381)=8.53, table 6), with the 
US wording being lower on invested effort compared with 
all other groups, UK (padj=0.045), NZ (padj<0.001) and 
experimental wording (padj=0.014), in line with our pilot 
findings. Given the degree of skew in the understanding 
outcome measures, we also ran non- parametric analyses 
as a robustness check. Non- parametric findings were in 
line with the parametric findings.
How much confidence did participants have in their answer 
regarding their beliefs about ‘John’s’ COVID-19 status?
An exploratory ANOVA found a small main effect of test 
result, F(1,1738)=48.6, with greater confidence for posi-
tive test results than negative (table 5). Likewise, there 
was a small main effect of wording, F(4,1738)=4.1, table 6; 
post- hoc Tukey tests suggested that participants seeing 
the NZ wording were less confident in their estimates 
of the likelihood that the test recipient had COVID-19 
(mean=64.0, 95% CI 61.2 to 66.7) than those viewing the 
UK wording (mean=70.3, 95% CI 67.5 to 73.1), p=0.004, 
or the control (mean=69.9, 95% CI 67.3 to 72.5), p=0.004. 
As the confidence measure exhibited skew, we also ran 
non- parametric analyses as a robustness check. Results 
were largely in line with the parametric findings; both a 
Figure 5 (A and B) The proportion of participants giving 
categorical 100% (A) or 0% (B) responses as to what ‘John’s’ 
viral test result means in each message wording group, for 
those who were told that ‘John’s’ result was (A) positive and 
(B) negative.
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main effect of test results and a main effect of wording 
emerged. Uncorrected Mann- Whitney tests additionally 
suggested a difference between the NZ wording and the 
US wording as well as the experimental wording. See 
figure 6.
Free text responses
Free text answers to why participants felt the test recipient 
should self- isolate were thematically coded by one of the 
authors into 1 of 10 themes: mistakenly remembering the 
direction of the test result; scepticism about the seriousness 
or existence of COVID-19; uncertainty about the validity 
of the test result (including quality of evidence concerns); 
John’s test result means he does not need to self- isolate; 
concern for the mental health, personal freedom, prac-
tical or financial implications of self- isolation; scepticism 
about the effectiveness of self- isolation; John’s symptoms 
mean he should self- isolate; John’s test result means he 
should self- isolate; general comments about self- isolation 
being important for public health, or ‘better safe than 
sorry’; other/not sure/forgotten result. Where more 
than one reason was given, the response was scored on 
the first mentioned (see figure 7).
For exploratory analyses looking at the effects of 
numeracy, education and ethnicity see online supple-
mental analysis 2.
DISCUSSION
Test, trace and isolate systems (both population- wide and 
as a specific requirement for entering work or educational 
environments) have been a core part of many countries’ 
responses to COVID-19, and they rely greatly on people’s 
behaviour upon receiving either a positive or negative test 
result. Studies have looked at the public’s behaviour in the 
real world when experiencing symptoms,40 or at factors 
affecting adherence to quarantine guidelines, which is 
generally low,41–43 although of course not just a matter of 
intentions, but also of difficulty.44 45 To our knowledge no 
studies have looked at the effects of information on, and 
interpretation of, COVID-19 test results as a part of this 
important pandemic mitigation response.
The interpretation of a positive or negative test result is 
not simple, because it depends on the prior likelihood of 
the condition. As of 2020, the UK’s NHS had decided to 
communicate the results of COVID-19 PCR tests with no 
uncertainty, in an apparent attempt to maximise clarity 
for the recipient; changes introduced in 2021 explicitly 
acknowledged a degree of uncertainty. New Zealand’s 
Ministry of Health had, by contrast, dedicated an entire 
website to trying to communicate the uncertainties. The 
USA’s Centers of Disease Control had taken the middle 
ground, merely adding the caveat that a recipient of a 
Table 9 Participant responses to ‘What is your best guess as to the percent chance that John actually had COVID-19 at the 
time of his test, given his test result?’, by test result and message viewed
Combination of test 
result and message 
viewed
N answering 48%–52% 
(percentage, 95% CI52)
N answering 0%








  Control 25/156
16.0% (11.0% to 22.6%)
0/156
0.0% (0% to 2.9%)
24/156
15.4% (10.5% to 21.9%)
  USA 37/165
22.4% (16.7% to 29.4%)
1/165
0.6% (0% to 3.7%)
26/165
15.8% (10.9% to 22.1%)
  New Zealand 30/186
16.1% (11.5% to 22.1%)
0/186
0.0% (0% to 2.4%)
12/186
6.5% (3.6% to 11.0%)
  UK 39/165
23.6% (17.8% to 30.7%)
1/165
0.6% (0% to 3.7%)
40/165
24.2% (18.3% to 31.3%)
  Experimental 57/200
28.5% (22.7% to 35.1%)
2/200
1.0% (0% to 3.8%)
28/200
14.0% (9.8% to 19.5%)
Negative test
  Control 59/200
29.5% (23.6% to 36.2%)
15/200
7.5% (4.5% to 12.1%)
3/200
1.5% (0.3% to 4.5%)
  USA 61/177
34.5% (27.9% to 41.7%)
14/177
7.9% (4.7% to 12.9%)
1/177
0.6% (0% to 3.5%)
  New Zealand 36/159
22.6% (16.8% to 29.8%)
7/159
4.4% (2.0% to 9.0%)
1/159
0.6% (0% to 3.8%)
  UK 58/178
32.6% (26.1% to 39.8%)
27/178
15.2% (10.6% to 21.2%)
0/178
0% (0% to 2.5%)
  Experimental 41/158
25.9% (19.7% to 33.3%)
11/158
7.0% (3.8% to 12.2%)
0/158
0% (0% to 2.9%)
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negative test result ‘probably’ does not have COVID-19. 
These three pieces of information are not comparable in 
their aims and audience—they are not all provided to test 
recipients when they are given their results—but we here 
compare their effects on the public’s interpretation of test 
results as a way of gauging how such information affects 
people’s natural understanding of such a test result.
Differences between response to positive versus negative test 
results
Preregistered analyses showed that participants thought the 
(symptomatic) recipient of a positive test result was more 
likely to have COVID-19 than the (symptomatic) recipient of 
a negative test result, and were more likely to say that such a 
recipient should then self- isolate. They also rated the positive 
test result to have a higher quality of evidence underlying it, 
and assessed it as more trustworthy. Exploratory analyses also 
implied that participants expressed more confidence in posi-
tive than negative results.
This suggests that, even with no information provided 
(i.e., in the control group), the UK public are aware that 
such test results are not perfectly accurate, and have a 
lower confidence in a negative test result than a positive 
test result. This is a reasonable belief for the scenario 
presented—where the pretest probability of having 
COVID-19 was stated as 50%—given that evidence from 
clinical adjudication, systematic reviews and community- 
based settings suggests that specificity has been higher 
than sensitivity for PCR tests in real- world settings1.
Differences in response to the different information (or none) 
accompanying results
Some differences in response were also seen among the 
groups that received different wording alongside the 
test result. In preregistered analyses, there was a sugges-
tion that those seeing the NZ wording found the results 
slightly less trustworthy, and they were also more likely 
than those who saw the UK wording to say that the test 
recipient should self- isolate. Exploratory findings built 
on these, suggesting that those who read the UK word-
ing’s unambiguous interpretation of the results tended 
to be more definitive in their interpretation as well: they 
were more likely to answer ‘100%’ as the likelihood of the 
recipient of a positive test result having COVID-19 and 
‘0%’ as the likelihood of the recipient of a negative test 
result having the disease. By contrast, those who read the 
NZ wording were the least likely to be so categorical in 
their interpretations (as well as being the least likely to 
answer ‘50%’, which can be taken as an indication of ‘I 
don’t know’). For those who had been shown negative 
test results, this trend carried through to participants’ 
Table 10 Participant responses to ‘John should now 
isolate himself from other people’, by test result and 
message viewed
Combination 
of test result 
and message 
viewed
N with maximum 
disagreement
(slider all of the 




N with maximum 
agreement
(slider all of the 




  Control 1/156
0.6% (0% to 3.9%)
78/156
50.0% (42.2% to 
57.8%)
  USA 0/165
0% (0% to 2.7%)
75/165
45.5% (38.0% to 
53.1%)
  New Zealand 1/186
0.5% (0% to 3.3%)
75/186
40.3% (33.5% to 
47.5%)
  UK 2/165
1.2% (0.1% to 
4.6%)
80/165
48.5% (41% to 56.1%)
  Experimental 3/200
1.5% (0.3% to 
4.5%)
82/200
41.0% (34.4% to 
47.9%)
Negative test
  Control 22/200
11.0% (7.3% to 
16.2%)
16/200
8.0% (4.9% to 12.7%)
  USA 9/177
5.1% (2.6% to 
9.5%)
22/177
12.4% (8.3% to 
18.2%)
  New Zealand 6/159
3.8% (1.6% to 
8.2%)
18/159
11.3% (7.2% to 
17.3%)
  UK 31/178
17.4% (12.5% to 
23.7%)
12/178
6.7% (3.8% to 11.5%)
  Experimental 14/158
8.9% (5.2% to 
14.4%)
15/158
9.5% (5.7% to 15.2%)
Figure 6 Participant confidence in their own estimates 
of the likelihood that the test recipient had COVID-19, 
by wording group (either no accompanying explanatory 
text (control wording), an experimental text based on the 
UK wording but with added clarification about the test 
uncertainties (experimental wording), or official text from 
one of three different countries, that is, New Zealand (NZ 
wording), UK (UK wording), USA (US wording)).
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Figure 7 The reasons participants gave for their response to how much they agreed with the statement that the test recipient 
(who was symptomatic) should isolate after receiving his test result, split by the result they were given for the recipient (positive 
or negative) and the additional information that they received alongside the test result (either no accompanying explanatory 
text (control wording), an experimental text based on the UK wording but with added clarification about the test uncertainties 
(experimental wording), or official text from one of three different countries, that is, New Zealand (NZ wording), UK (UK wording), 
USA (US wording)).
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reactions to whether or not the recipient should self- 
isolate or not.
The fact that the effect of the UK’s official interpreta-
tion of the result appeared to lead some participants to 
interpret a positive result as meaning that the recipient 
was 100% likely to have COVID-19 is not a major concern; 
100% may not be far off the true rate given the low false 
positive rate for symptomatic individuals. However, what 
is more worrying is that, as some commentators had 
feared,7 the wording also appeared to lead some partic-
ipants to believe that a negative result meant the recip-
ient had a 0% chance of having COVID-19, and that 
this appeared to carry through to their beliefs that he 
should not self- isolate, despite being symptomatic. The 
experimental information, based on the UK wording but 
incorporating what we hoped was clearer advice around 
a negative test result, did not appear to discourage this 
view as much as we had hoped, although the free text 
responses in this group did seem to suggest an increase 
in the number of people who picked up on the fact that a 
symptomatic person should continue to self- isolate.
Those in the NZ wording condition also, in explor-
atory findings, rated themselves less confident in their 
judgments of the likelihood that the test recipient had 
COVID-19 at the time of the test, given the test results. 
The NZ wording, with its emphasis on the uncertainty of 
the tests, appears, then, to have influenced participants 
in this wording condition to come away with a more 
nuanced view of what a COVID-19 test result means: they 
thought the results less trustworthy, were less likely to 
think them definitive, and were more cautious in their 
behavioural interpretation of a negative test. Whether 
their lower confidence in their answer is a good or bad 
thing is arguable.
It was also interesting that those seeing the UK wording 
seemed to interpret results not only as more definitive 
than those in the other wording conditions, but also than 
those in the control group (table 8), which yields insight 
into people’s beliefs about test result interpretation prior 
to being shown further information.
Finally, exploratory results suggested that participants 
rated the NZ wording harder to understand, and the US 
wording as the one requiring the least effort, both in line 
with our manipulation check of time spent reading the 
intervention texts (see online supplemental informa-
tion). The US wording was shorter than the NZ wording, 
so it would be expected that participants take more time 
to read the NZ wording. Additionally, given that the NZ 
text provided information on statistical uncertainty (e.g., 
false positives and false negatives), which requires more 
cognitive effort in order to comprehend the content 
compared with a text that does not describe uncertainties 
in such depth, the findings of understanding and effort 
invested are not too surprising.
The free text that participants gave to explain why they 
thought the test recipient should or should not self- isolate 
often emphasised a precautionary approach. A large 
number chose to be ‘better safe than sorry’, although 
fewer among those who were given information about 
test interpretation from the UK’s NHS website. From 
those who saw the NZ wording and a negative test result, 
the free text responses suggest that the larger propor-
tion of people saying he should self- isolate were doing so 
because of uncertainties about the test result (rather than 
because he was symptomatic). Very few participants were 
sceptical about the seriousness or existence of COVID-
19, about the effectiveness of self- isolation, or that the 
potential negative consequences of self- isolation (e.g., 
financial, effects on personal freedom or mental health) 
outweighed any potential positives in terms of public 
health. These free text responses bolster the interpreta-
tion of the quantitative results.
This study has a number of limitations. The scenario given 
to participants, of a high suspicion (50% chance) that the 
test recipient had COVID-19 was not clinically likely unless 
they were a health worker (or already hospitalised because of 
symptoms) given the prevalence of COVID-19 at the time our 
study was conducted. We did not introduce either of these 
factors as we felt they would be likely to bias participants’ 
interpretation of either the test result or their behavioural 
recommendation. However, depending on overall prev-
alence, in many cases the prior probability will be much 
lower than 50% and we have not tested how this would affect 
participants’ interpretations. We also presented participants 
with text taken from official websites, rather than the much 
shorter text they are likely to receive (e.g., by SMS message) 
alongside their test result. Additionally, the question asking 
participants to give a numerical probability of the chances of 
the likelihood of COVID-19 still resulted in a high propor-
tion of people indicating that they were uncertain how to 
respond.
There were also differences in results between the pilot and 
the main study. Some of these may be due to improvements 
we made to the questionnaire after the pilot: the difference 
in how participants were asked to input percentages when 
asked the test recipient’s chance of having COVID-19 (a 
slider vs a text box in the pilot), which decreased the number 
of participants who provided answers of 50%—although 
many people still answered 50% even when using the slid-
erscale—and putting the test result in bold in an effort to 
ensure that it was not missed.
Finally, our study participants were only UK residents who 
responded to the online survey invitation; this means they 
should not necessarily be taken as representative of the UK 
public as a whole, and the public of other countries may have 
had different reactions.
Our conclusions, however, are that although the UK 
public have a natural sense of the comparative reliability 
of positive and negative test results when the prior proba-
bility of infection is high, presenting them with an unam-
biguous interpretation encourages a belief that the results 
are 100% certain.
CONCLUSIONS
Test results are often misinterpreted, particularly if the 
prevalence of the condition being tested for is very low.46 
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The overwhelmingly large effect of the prior probability 
of a positive test (strongly influenced by the local preva-
lence, as well as by the presence and type of symptoms) on 
the interpretation of a test result is not only unintuitive, 
it also makes it difficult to communicate the numerical 
uncertainty around an individual’s test result, because this 
prior probability is so variable. Added to these complica-
tions are the difficulties associated with assessing sensi-
tivity and specificity of COVID-19 PCR tests in a real- world 
context, where additional uncertainties are introduced by 
users carrying out the swabbing themselves, as opposed 
to a laboratory context. However, the results of this study 
show that the public are quite capable of understanding 
more nuanced explanations than many authorities give 
them credit for.
It may also be worth communicating that negative 
results should be confirmed with a second test when 
symptomatic, although even this should not be commu-
nicated in such a way as to give undue confidence. With 
plausible assumptions, Watson et al’s1 table 1 estimates 
that someone with a prior probability of 50% will have 
a post- test probability of 24% after a single negative test, 
and of 9% after two negative tests assuming indepen-
dence of test failures, though in the real world causes of 
test failure can be correlated.
We applaud the UK NHS for modifying their original 2020 
website text in such a way as to acknowledge uncertainty and 
to be more clear about self- isolation, in line with our sugges-
tions. This seems likely to discourage the belief that results 
are 100% certain: our experimental wording was directly 
based on the UK wording with a few small tweaks, and did 
not appear to inspire the same degree of categorical inter-
pretation. However, it did not appear to affect the belief that 
a symptomatic person with a negative test result could stop 
self- isolating. Only the NZ wording had this effect, and other 
agencies might consider adopting wording more similar to 
that used by the New Zealand Ministry of Health. Its rating of 
being harder to understand (and possible follow- on effects to 
the understanding of a positive test) should be borne in mind, 
though we did not observe evidence that those reading this 
wording would be less apt to self- isolate after a positive test. 
Importantly, the straightforward advice that a symptomatic 
person should continue to self- isolate after a single negative 
test result needs to be given very strongly in all governments’ 
information, in line with UK NHS and government guidance 
which states that individuals who feel unwell should continue 
to stay at home.3 47
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